September 16, 2020 5:05 pm Patient Management FDA Publishes COVID-19 Diagnostic Test Performance Data The U.S. Food and Drug Administration has released comparative performance data for some authorized COVID-19 molecular diagnostic tests. This move will support physicians and practices in their efforts to weigh the efficacy of various tests. To learn more, click here, and to view the data, click here. SHARE News & Knowledge All Curi recommendations are based on current CDC criteria at the time of publication. CDC guidance for SARS-CoV-2 infection may, or may not, be adopted by state and local health departments to respond to rapidly changing local circumstances. Providers should always check with their local health department to see if the CDC’s guidance on any given topic has been modified (particularly if more restrictive) from the CDC’s recommended guidelines. Follow this link https://www.cdc.gov/publichealthgateway/healthdirectories/index.html for contact information to your state/local health department. If local recommendations vary from those of the CDC, and you are unsure what recommendations to follow, then it is safer to follow the more restrictive guidelines/recommendations.